Drug discovery is a long, costly, and arduous process that requires dedicated manpower, financial resources, and infrastructure. The pharmaceutical industry has witnessed radical changes in the past two decades, in terms of a shift toward biologics, patent expiration, and unprecedented downsizing of internal discovery of big pharmaceuticals. All of this has accelerated the adoption of outsourcing activities.
Based on the Drug Discovery Outsourcing market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Drug Discovery Outsourcing market covered in Chapter 5:
Jubilant Biosys
GenScript
Charles River
Oncodesign Biotechnology
QIAGEN
Pharmaceutical Product Development, LLC
Albany Molecular Research, Inc
Dalton Pharma Services
Thermo Fisher Scientific, Inc.
LabCorp
EVOTEC
WuXi AppTec
DiscoverX Corporation
Merck & Co., Inc.
In Chapter 6, on the basis of types, the Drug Discovery Outsourcing market from 2015 to 2025 is primarily split into:
Small Molecules
Large Molecules (Biopharmaceuticals)
In Chapter 7, on the basis of applications, the Drug Discovery Outsourcing market from 2015 to 2025 covers:
Respiratory System
Pain and Anesthesia
Oncology
Ophthalmology
Hematology
Cardiovascular
Endocrine
Gastrointestinal
Immunomodulation
Anti-Infective
Central Nervous System
Dermatology
Genitourinary System
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Summary:
Get latest Market Research Reports on Drug Discovery Outsourcing. Industry analysis & Market Report on Drug Discovery Outsourcing is a syndicated market report, published as Global Drug Discovery Outsourcing Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Drug Discovery Outsourcing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.